Inicio » Publicaciones » Comparison of bezafibrate vs lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients.
Comparison of bezafibrate vs lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients.
Autores
ZAMBRANA GARCÍA, JOSÉ LUIS, Velasco F , Castro P , Concha M , Valles F , Montilla P , Jiménez-Perepérez J , Lopez- Miranda J , Perez-Jimenez F
